Search Results for agency_names:"Centers for Disease Control and Prevention"

The Centers for Disease Control and Prevention (CDC) is holding a meeting on March 11-12, 2025, which will be closed to the public. This meeting is organized by the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel to review grant applications related to research on preventing interpersonal violence affecting children and youth. The discussions will be confidential to protect trade secrets and personal information. For more details, contact Aisha L. Wilkes, the Scientific Review Officer at the CDC.

The Centers for Disease Control and Prevention (CDC) announced a closed meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel to review grant applications. This virtual meeting will take place on February 24-25, 2025, from 11:00 a.m. to 5:00 p.m. EST. The meeting is closed to protect sensitive information, such as trade secrets and personal data, in compliance with federal regulations. Contact Dan Hartley at the CDC for more information.

The Centers for Disease Control and Prevention (CDC) has announced a public meeting of the Advisory Committee on Immunization Practices (ACIP) scheduled for February 26-28, 2025. The meeting will address various vaccines, such as those for COVID-19, influenza, and RSV, with some subject to voting on recommendations. Public written comments can be submitted between February 3-17, 2025, and there will also be opportunities for oral comments during the meeting. The meeting will be live-streamed online, allowing public participation, with comment submission procedures detailed on the CDC website.

The Centers for Disease Control and Prevention (CDC) submitted an information collection request for the "Assessment of Ill Worker Policies Study" to the Office of Management and Budget. This research, involving collaboration with various agencies and local health programs, aims to evaluate if an educational intervention can improve restaurant policies regarding sick workers. The study involves observing and interviewing restaurant managers across different locations to see if policy changes occur following the intervention. Feedback from participating partners helped refine this study, which was initially delayed due to the COVID-19 pandemic.

The National Institute for Occupational Safety and Health (NIOSH) has published the 2024 list of hazardous drugs used in healthcare settings, which identifies medications that could be dangerous for healthcare workers handling them. This list update removes two drugs, liraglutide and pertuzumab, based on reconsideration of the risks they pose in workplace settings. Public commentary and input from experts helped inform changes to the list. The update aims to guide healthcare employers in maintaining safe workplaces by providing information on the potential hazards of specific drugs.

The Centers for Disease Control and Prevention (CDC) is inviting public comments on the ongoing research data collection process by the National Center for Health Statistics (NCHS). This involves feedback on the Research Data Center's (RDC) proposal for granting access to confidential data, necessary for researchers to conduct their projects. The notice is part of an effort under the Paperwork Reduction Act to reduce public burdens and enhance data utility. Comments must be submitted by February 3, 2025, and should follow submission guidelines through the federal eRulemaking portal or by mail.

The Centers for Disease Control and Prevention (CDC) is inviting public comment on a proposed study, as per the Paperwork Reduction Act of 1995, aimed at improving HIV diagnosis and care services using Point-of-Care Nucleic Acid Tests (NATs). This study, known as the Greater Access and Impact with NAT (GAIN) Study, seeks to identify challenges and supportive factors in implementing these tests in clinical settings and assess their effectiveness in speeding up HIV prevention and care. Public comments are invited until March 10, 2025, and the CDC is asking for insights on the necessity, accuracy, and cost-effectiveness of the data collection process associated with this study.

The Centers for Disease Control and Prevention (CDC) announced a closed meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel, scheduled for March 11, 2025. The meeting, which will be held via teleconference, will focus on reviewing and evaluating grant applications. It is closed to the public because discussions might reveal trade secrets, commercial property, or private information about individuals involved in the grant applications. For more details, interested parties are encouraged to contact Catherine Barrett, the Scientific Review Officer at the CDC.

The Centers for Disease Control and Prevention (CDC) has issued an order requiring passengers flying to the United States from foreign countries to present proof of a negative COVID-19 test or documentation of recovery from the virus. This order, effective January 26, 2021, supersedes a previous order and aims to prevent the spread of COVID-19, including new variants, by setting requirements for airlines and passengers. Exemptions include certain federal law enforcement and military personnel, as well as cases of emergency travel under specific circumstances. Airlines must verify and retain documentation for compliance, and failure to do so may result in penalties.

The Centers for Disease Control and Prevention (CDC) announced a closed meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel. The meeting is scheduled for March 4, 2025, and will be held via video conference. The purpose of this meeting is to review and evaluate grant applications related to Occupational Safety and Health Training Project Grants. Due to the potential disclosure of confidential or personal information, the meeting will not be open to the public.